Steffen McLouth, Laurie E <br/><br/>
Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice.  [electronic resource] 

 -  Clinical lung cancer  05 2020 
 - 255-263.e4 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1938-0690 
<br/><br/><label>Standard No.: </label>10.1016/j.cllc.2019.11.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cross-Sectional Studies<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immune Checkpoint Inhibitors--therapeutic use<br/>Immunotherapy--mortality<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Patient Reported Outcome Measures<br/>Practice Patterns, Physicians'--statistics & numerical data<br/>Prognosis<br/>Survival Rate